Sustainability

Founded in November 2006, Profarma’s Social Responsibility Institute seeks to promote citizenship and social inclusion, as well as promote wellbeing and provide assistance in solidarity of those in need, regardless of the distance.

During its first year, the Institute developed social projects, permanent and targeted support actions and also implemented actions targeting the Company’s employees.

The social projects developed include the “Project to Support Children with Cystic Fibrosis”, which raised funds with the sale of bracelets (which also served as social currency) and enabled the acquisition of one school kit and two boxes of basic food staples for each of the 820 children identified by the survey carried out by the Brazilian Mucoviscoidosis Assistance Association.

Other projects were based on raising funds from pharmaceutical companies, logistics providers and other collaborators to assists institutions focused on treating children with cancer, HIV, AIDS and osteogenesis

Profarma’s operations comprise the wholesale of pharmaceutical products through distribution centers where products are stored, separated and packaged. The Company does not carry out any activities that are strictly controlled by environmental authorities, once the handling and storage of products do not have a direct and adverse impact on environment.

Profarma’s operations do not require it to dispose (discard) of drugs, including those that are expired, present production problems, among others. In general, drugs that should be disposed of are returned to their respective laboratories or sent to companies that hold proper licenses from environmental bodies or authorizations from ANVISA for handling disposal procedures.

The Company has not received hitherto any official notifications from any governmental bodies regarding environmental aspects or regularization of its distribution centers. In addition, Profarma is in good standing before governmental authorities as to the use of distribution centers for storing purposes.

In recent years, Profarma received awards from specialized publications, business associations, clients and suppliers for the quality of its services. Among these awards we highlight the following:

2014 Institutional Investor Awards

Max Fischer, CFO and IR of Profarma, was elected the best CFO in Latin America for the healthcare segment in the opinion of sell side analysts. This result is part of the 2014 Latin American Executive Team ranking sponsored by the Institutional Investor magazine, which features the best IR professionals in Latin America, ranked by Sell Side analysts (who work in banks and brokerages, evaluating stocks performance to recommend to their clients) and Buy Side analysts (those who make internal assessments to funding managers, recommending the purchase or sale of stocks for assets portfolios). 409 portfolio managers and Buy Side analysts, and other 372 Sell Side analysts have participated in this year’s survey, having evaluated 16 sectors. With global circulation and over 50 years of existence, the Institutional Investor magazine is one of the important publications on financial markets in the world.

2011 Institutional Investor Awards

Max Fischer, CFO and IR of Profarma, was elected the best IR professional in Latin America for the healthcare segment in the opinion of sell side analysts. This result is part of the 2011 Latin American Executive Team ranking sponsored by the Institutional Investor magazine, which features the best IR professionals in Latin America, ranked by Sell Side analysts (who work in banks and brokerages, evaluating stocks performance to recommend to their clients) and Buy Side analysts (those who make internal assessments to funding managers, recommending the purchase or sale of stocks for assets portfolios). 284 Buy Side analysts, and other 288 Sell Side analysts have participated in this year’s survey, having evaluated 13 sectors. With global circulation and 50 years of existence, the Institutional Investor magazine is one of the important publications on financial markets in the world.

Best and Largest Companies – Revista Exame 2010

Profarma is among the top 100 private groups acting in Brazil, according to the ranking of the Best and Largest companies, evaluated by Revista Exame in July 2010. We were also classified as the 24th largest commerce group by sales, and when analyzing the wholesale sector, Profarma is the 5th top company, being the only one from the 15 companies analyzed from this segment, to be listed in the stock market. These classifications are a consequence from a work of more than 2.200 workers, which lead the value of the Company into; evolution, results accomplishments, strategic success and commitment with its publics, being them, customers, industry partners or shareholders.

IR Magazine Awards Brazil 2010

Profarma was indicated for two prizes from IR Magazine Awards Brazil 2010. The Company was among the top 5 in the category “ Best encounter with the analyst community” (small & mid cap companies), and Max Fisher, Financial and IR Director was elected the fourth “Best IR businessman (small & mid cap companies).

Top 200 Largest groups in the country - Revista Valor Grandes Grupos

In December 2008, the magazine Valor Grandes Grupos released its ranking of the top 200 groups in Brazil, 2007. Profarma was classified in the 110th position, going up 14 positions in relation to the year 2006.

Anual Balance 2008

In the 32nd issue of Balanço Anual da Gazeta Mercantil, published on October, 2008, hundreds of companies had their performances analyzed and Profarma was ranked in the 76th position among the 100 top companies in the south east region. If considered the evaluation of the companies as commerce / Retail of the pharmaceutical products, hygiene and cleaning segment, Profarma leads the ranking.

Premio Respeito ao Investidor Individual

Profarma received the Premio Respeito ao Investidor, given to publicly traded companies that participate in one or two editions of the Expo Money circuit 2008. Profarma received this prize during the opening of the 6th Expo Money 2008 which happened on September 2008.

Publicly Traded Companies yearbook 2008

In the second yearbook edition of the publicly traded company analysis, launched in the first fortnight of July/2008, among the hundreds of companies that negotiate in the stock market, Profarma, the only company in the pharmaceutical product distribution segment that have shares in the highest corporative governance level, appears in the 57th position in net revenue, once analyzed by the private sector category. In the Brazilian company category, Profarma occupies the 59th position, and if analyzed in the family company category its position goes up to the 10th.

The top 500 companies in Latin America

On July, 21st, 2008, the magazine America Economia, published its ranking of the top 500 companies in Latin America, 2007, and according to their sales, it ranked Profarma in the 351st position. Going up 37 positions if compared to the year 2006, Profarma kept up with the drift of the other Brazilian companies – from the top 500 companies, the ones that most grew in relation to the previous years were the Brazilian companies

The top Best and Largest Companies in the Country – Revista Exame

In the ranking published by Revista Exame on July, 2008, Profarma was classified as the 83rd company from the 100 biggest sales groups.

Indexes

Copyright Profarma 2016 - All rights reserved

imgCapctha